Dr. Claire Lugrin is a postdoctoral researcher at Roche pRED in Basel, where she focuses on developing digital biomarkers for Huntington's disease using passive monitoring technologies. She earned her PhD in Neuroeconomics from the University of Zurich, where she studied the neural and behavioral mechanisms of human social behavior through advanced cognitive testing, fMRI, and computational modeling. Prior to her doctoral studies, Claire worked at MindMaze, contributing to the development of digital solutions for stroke rehabilitation. Her multidisciplinary expertise spans neuroscience, digital health, and computational approaches to improve patient outcomes.
